Rheumatoid Arthritis, Osteoarthritis (Arthrosis, Degenerative Joint Disease), Ankylosing Spondylitis: Recommended Starting Dose: 20 mg given as a single daily dose. The majority of patients will be maintained on 20 mg daily. A relatively small group of patients may be maintained on 10 mg daily. Some patients may require up to 30 mg daily given in single or divided doses. Long-term administration of doses ≥30 mg carries an increased risk of gastrointestinal side effects.
Acute Gout: Therapy should be initiated by a single dose of 40 mg followed on the next 4-6 days with 40 mg daily, given in single or divided doses. Feldene Flash is not indicated for long-term management of gout.
Acute Musculoskeletal Disorders: Therapy should be initiated with 40 mg daily for the first 2 days given in single or divided doses. For the remainder of the 7-14 day treatment period, the dose should be reduced to 20 mg daily.
Children: Dosage recommendations have not been established.
Administration: Feldene Flash should be placed on the tongue to disperse and then swallowed with the saliva. It dissolves almost instantly in the mouth in the presence of saliva.